A Tort Blemish

  • by: |
  • 02/12/2010
A new blemish on the tort bar.

Last week, over-ruling a lower court and obvious logic, a New Jersey appeals court ruled that a trial court should reconsider allowing a so-called “expert” to testify in Palazzolo v. Hoffman La Roche, Inc, a lawsuit alleging that Accutane causes depression. The issue involves whether an expert should be allowed to offer testimony on a study that was (1) considered flawed and (2) was funded by plaintiffs and lawyers involved in the litigation.

The trial court in New Jersey ruled that Doug Bremner, an Emory University professor, should not be allowed to offer expert testimony on his “flawed study.” Now the appeals court has remanded the case to the trial court "to consider whether Bremner should be allowed to testify on causation, without reference to the study.” (The trial judge decided the study was central to his opinion and dismissed the case.)

To quote that well-known legal expert, Madonna – not!

There are two main problems, one scientific and other ethical. Problem #1 is Bremner’s reliance on PET scans to find metabolic changes in the brains of acne patients treated with Accutane (the problem being that all parties agreed that that PET scans could not diagnose depression). The second, as already mentioned, is that Bremner’s study was commissioned specifically for use in the litigation by plaintiffs and lawyers involved in the litigation.

Can you imagine the hue and cry if a pharmaceutical company had done this? Since sunshine is always the most potent disinfectant, how about a Sunshine Act for the tort bar?

To quote the English social reformer, William Ellery Channing, “It is far more important to me to preserve an unblemished conscience than to compass any object however great.”


CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog